Table 1.
CD44 score, progression, and survival
| Status | N | % | CD44 score mean±SD | p value | |
|---|---|---|---|---|---|
|
| |||||
| All patients | No progression | 27 | 27.8 | 35.7±56.6 | 0.473 |
| Definite progression | 70 | 72.2 | 46.1±66.3 | ||
|
| |||||
| Alive | 24 | 26.4 | 44.4±56.8 | 0.804 | |
| Dead | 67 | 73.6 | 40.7±64.4 | ||
|
| |||||
| Chemotherapy only | No progression | 15 | 29.4 | 20.7±29.9 | 0.011 |
| Definite progression | 36 | 70.6 | 60.3±76.6 | ||
|
| |||||
| Alive | 12 | 25.0 | 24.2±28.7 | 0.041 | |
| Dead | 36 | 75.0 | 55.4±73.8 | ||
|
| |||||
| Chemotherapy plus Vismodegib |
No progression | 12 | 26.1 | 54.6±75.8 | 0.233 |
| Definite progression | 34 | 73.9 | 31.2±50.1 | ||
| Alive | 12 | 27.9 | 64.6±70.9 | 0.032 | |
| Dead | 31 | 72.1 | 23.6±47.0 | ||